Advances in Radiation Therapy. Группа авторов

45King AD, Thoeny HC: Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. Cancer Imaging 2016;16:23.

46Begg AC, Haustermans K, Hart AA, Dische S, Saunders M, Zackrisson B, et al: The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 1999;50:13–23.

47Perri F, Pacelli R, Della Vittoria Scarpati G, Cella L, Giuliano M, Caponigro F, et al: Radioresistance in head and neck squamous cell carcinoma: biological bases and therapeutic implications. Head Neck 2015;37:763–770.

48Wang JZ, Li XA: Impact of tumor repopulation on radiotherapy planning. Int J Radiat Oncol Biol Phys 2005;61:220–227.

49Troost EG, Bussink J, Hoffmann AL, Boerman OC, Oyen WJ, Kaanders JH: ¹⁸F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors. J Nucl Med 2010;51:866–874.

50Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311–322.

51Soloviev D, Lewis D, Honess D, Aboagye E: [¹⁸F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment. Eur J Cancer 2012;48:416–424.

52Debebe SA, Goryawala M, Adjouadi M, McGoron AJ, Gulec SA: ¹⁸F-FLT positron emission tomography/computed tomography imaging in pancreatic cancer: determination of tumor proliferative activity and comparison with glycolytic activity as measured by ¹⁸F-FDG positron emission tomography/computed tomography imaging. Mol Imaging Radionucl Ther 2016;25:32–38.

53Tehrani OS, Shields AF: PET imaging of proliferation with pyrimidines. J Nucl Med 2013;54:903–912.

54Hoeben BA, Troost EG, Span PN, van Herpen CM, Bussink J, Oyen WJ, et al: ¹⁸F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome. J Nucl Med 2013;54:532–540.

55Bollineni VR, Kramer GM, Jansma EP, Liu Y, Oyen WJ: A systematic review on [¹⁸F]FLT-PET uptake as a measure of treatment response in cancer patients. Eur J Cancer 2016;55:81–97.

56Bussink J, Kaanders JH, Rijken PF, Raleigh JA, van der Kogel AJ: Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiat Res 2000;153:398–404.

      W. Woliner-van der Weg, PhD or J. Bussink, MD, PhD

      Department of Radiation Oncology, Radboud University Medical Center

      P.O. Box 9101

      NL–6500 HB Nijmegen (115) (The Netherlands)

      E-Mail [email protected] or [email protected]